MariMed Inc. ( MRMD) - Key Metrics
MRMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.11 | -$0.01 | $0.01 | $0.01 |
| 2025Q3 | $0.10 | -$0.01 | $0.01 | $0.01 |
| 2025Q2 | $0.10 | $0 | $0 | $0 |
| 2025Q1 | $0.10 | -$0.01 | $0 | $0 |
MRMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -2.96% | -1.88 |
| 2025Q3 | -2.75% | -4.96 |
| 2025Q2 | -1.81% | -5.30 |
| 2025Q1 | -1.06% | -1.65 |
MRMD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.10% | ? |
| 2025Q4 | 9.07% | 0.39% |
| 2025Q3 | 4.04% | 0.14% |
| 2025Q2 | -0.96% | 0.09% |
| 2025Q1 | 2.86% | 0.16% |
MRMD
Price: $0.08
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.05 USD
P/E Ratio: -1.68
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 278400
Market Capitalization: 31.9 million